The HeLiX (Hemorrhage During Liver Resection: traneXamic Acid) Trial

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

1,386

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

August 31, 2022

Study Completion Date

August 31, 2027

Conditions
CancerTumourSurgery
Interventions
DRUG

Tranexamic acid (TXA)

1 g TXA bolus injection + 1 g TXA infusion from induction over 8 hours

DRUG

Normal saline

1 g saline bolus injection + 1 g saline infusion from induction over 8 hours

Trial Locations (11)

Unknown

Mayo Clinic, Rochester

T2N 2T9

Foothills Hospital, Calgary

V1Y 1T2

Kelowna General Hospital, Kelowna

B3H 2YR

Queen Elizabeth II Health Sciences Centre, Halifax

L8L 8E7

Hamilton Health Sciences, Hamilton

K7L 2V7

Kingston General Health Research Institute, Kingston

N6A 5W9

London Health Sciences Centre, London

M4N 3M5

Sunnybrook Health Sciences Centre, Toronto

M5G 2C4

University Health Network, Toronto

M6R 1B5

St. Joseph's Health Centre, Toronto

H3A 1A1

McGill University Health Centre, Montreal

All Listed Sponsors
collaborator

HepatoPancreaticoBiliary (HPB) Concept Team

UNKNOWN

lead

Sunnybrook Health Sciences Centre

OTHER